Global Cannabidiol Market Overview:
Cannabidiol (CBD) is one of the hundreds of cannabinoids that are found in the cannabis plant. This is a naturally occurring substance, can be extracted & mixed with a carrier oil, often hemp seed or coconut, to create CBD oil. Cannabidiol oil can be derived from two different species of cannabinoids such as marijuana and hemp. Rising awareness about the health benefits of Cannabidiol is the major factors that are expected to drive the growth of the global Cannabidiol market. The demand for Cannabidiol is increasing around the globe owing to their capacity to cure various ailments in the human body. Cannabidiol in the form of CBD oil is used for the protection from Alzheimer's disease and has anti-inflammatory properties. It also benefits in the treatment of epilepsy and mental health disorders. The adoption rate of Cannabidiol is increasing because they help in drug withdrawal. It is highly recommended, as it can suppress the growth of cancer cells to prevent cancer. Some of the key players profiled in the study are ENDOCA BV (Netherlands), CBD American Shaman (United States), Isodiol International Inc. (Canada), Medical Marijuana Inc. (United States), Aurora Cannabis Inc. (Canada), Cannoid LLC (United States), Canopy Growth Corporation (Canada), CV Sciences, Inc. (United States), Elixinol LLC (United States) and NuLeaf Naturals, LLC. (United States).
On the basis of geography, the market of Cannabidiol has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Disease Indication, the sub-segment i.e. Anxiety will boost the Cannabidiol market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Growing Awareness Regarding Health benefits of CBD oil
- Globally Increasing Millennial Population and Rising E-Commerce Industry
- Increasing Legalization of Cannabis-Based Products
- Legalization of Cannabis for Medicinal and Recreational Activities
- High Cost of the Product
- Availability of Low Yield
- Emerging Markets and The advent of advanced cultivation processes
- Growing Investments made for the Production of Cannabis Oil
- Lack of Harvesting Innovations and Processing Facilities
- Strict Government Regulations in Some Countries
Major Market Developments:
March 4, 2019: Aurora Completes Whistler Medical Acquisition. The Transaction provides Aurora with a premium and differentiated organic certified product suite, expanding both its medical and consumer offerings, and reinforcing Aurora's presence in the well-established west coast cannabis market.
On 21 Jan. 2019, Canopy Growth Corporation has announced the expansion of its business in the European regions such as the United Kingdom and Poland where its medically-focused business Spectrum Cannabis continues to build a sophisticated, pan-European cannabis production as well as distribution network serving the needs of physicians and their patients throughout the continent.
In the United States, Food and Drug Administration approved the CBD drug Epidiolex for treatment of two epilepsy disorders. Also, The U.S. Drug Enforcement Administration (DEA) has assigned Epidiolex a Schedule V classification as well as non-Epidiolex CBD remains a Schedule I drug prohibited for any usage. In 2018, the World Health Organization recommended that CBD remain unscheduled. CBD is not scheduled under any United Nations drug control treaties.
The companies are exploring the market in new regions by adopting mergers & acquisitions, expansions, investments and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Cannabidiol Products manufacturers, Raw material suppliers, Hospitals, Government and research organizations, Distribution consultancies and End users
Major Objectives Focused through this Study
To define, describe, and forecast the Global Cannabidiol market on the basis of product [Food Grade and Pharmaceutical Grade] , application [Medical and Recreational], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Cannabidiol market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Cannabidiol industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are FOLIUM BIOSCIENCES (United States), Green Roads Wellness (United States), Kazmira LLC (Orochem Technologies) (United States) and Charlotte's Web (CWB Holdings, Inc.) (United States).
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Cannabidiol market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.